Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pulmonary therapeutics Market Research Reports

Titlepublishedprice

Pulmonary Embolism - Pipeline Review, H1 2017

By Global Markets Direct
"...... br /> Pulmonary embolism is the sudden blockage of a major blood vessel (artery) in the lung, usually by a blood clot. Symptoms include shortness of breath, chest pain, cough, leg pain or swelling, excessive sweating, rapid or irregular heartb......"
15-Mar-2017$2000

Pulmonary Arterial Hypertension - Pipeline Review, H1 2017

By Global Markets Direct
"...... blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms include chest pain, fatigue, passing out suddenly, and swelling of the legs (edema). Risk factors include family history, age, obes......"
08-Mar-2017$2000

Global Pneumonia Partnering 2010-2017

By Current Partnering
"...... ments since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by co......"
01-Mar-2017$1495

Global COPD Partnering 2010 to 2017

By Current Partnering
"...... e 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z,......"
01-Mar-2017$1495

Global Idiopathic Pulmonary Fibrosis Partnering 2010 to 2017

By Current Partnering
"...... nary Fibrosis Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top de......"
01-Mar-2017$1495

Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ic Pulmonary Fibrosis Report is to understand the market and pipeline status of the drugs around the Idiopathic Pulmonary Fibrosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designin......"
01-Jan-2017$2000

Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2017

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Jan-2017$1250

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast To 2023

By Delve Insight
"...... torical and forecasted data of Chronic Obstructive Pulmonary Disease (COPD) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet......"
01-Jan-2017$2750

Klebsiella Pneumoniae Infections-Pipeline Insights, 2017

By Delve Insight
"...... cluding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pa......"
01-Jan-2017$1250

Lung Infections-Pipeline Insights, 2017

By Delve Insight
"...... ND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations ......"
01-Jan-2017$1250